BlackRock Amends DaVita Stake, Updates Ownership as of Dec 31, 2023
Ticker: DVA · Form: SC 13G/A · Filed: 2024-01-31T00:00:00.000Z
Sentiment: neutral
Topics: institutional-ownership, amendment, healthcare, passive-investment
TL;DR
**BlackRock updated its DaVita stake, showing its holdings as of year-end 2023.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 31, 2024, indicating its ownership of DaVita Inc. common stock as of December 31, 2023. This filing, Amendment No. 8, updates their previous disclosures regarding their stake in the healthcare services company. This matters to investors because BlackRock is a major institutional investor, and changes in their reported holdings can signal shifts in their investment strategy or outlook on DaVita's future performance.
Why It Matters
This filing shows BlackRock's updated position in DaVita, providing transparency on a significant institutional investor's holdings, which can influence market perception and trading decisions.
Risk Assessment
Risk Level: low — This is a routine amendment filing by a large institutional investor and does not inherently signal a high-risk event for the company.
Analyst Insight
An investor should note that BlackRock, a major institutional holder, has updated its position in DaVita. While this filing doesn't disclose the exact change in share count or percentage, it confirms their continued interest as of year-end 2023. Investors should look for the detailed ownership percentage within the full filing to understand the magnitude of BlackRock's stake and any changes from previous reports.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- DAVITA INC. (company) — the subject company whose common stock is being reported
- December 31, 2023 (date) — the date of the event which requires the filing of this statement
- January 31, 2024 (date) — the date the SC 13G/A was filed
- Amendment No: 8 (number) — the specific amendment number of this filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 8)' sections.
Who is the 'Subject Company' in this filing?
The 'Subject Company' is DAVITA INC., identified by 'COMPANY CONFORMED NAME: DAVITA INC.' and 'Name of Issuer: DAVITA INC' in the filing.
Who is the 'Filed By' entity in this document?
The 'Filed By' entity is BlackRock Inc., as indicated by 'COMPANY CONFORMED NAME: BlackRock Inc.' in the 'FILED BY' section.
What is the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' is December 31, 2023, as explicitly stated in the filing.
What is the CUSIP Number for the securities reported?
The CUSIP Number for the Common Stock of DAVITA INC. is 23918K108, as listed under '(CUSIP Number)'.
From the Filing
0001086364-24-005987.txt : 20240131 0001086364-24-005987.hdr.sgml : 20240131 20240131140826 ACCESSION NUMBER: 0001086364-24-005987 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240131 DATE AS OF CHANGE: 20240131 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-47431 FILM NUMBER: 24582131 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc. CENTRAL INDEX KEY: 0001364742 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] ORGANIZATION NAME: 02 Finance IRS NUMBER: 320174431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-810-5300 MAIL ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock, Inc. DATE OF NAME CHANGE: 20060929 FORMER COMPANY: FORMER CONFORMED NAME: New BlackRock, Inc. DATE OF NAME CHANGE: 20060601 SC 13G/A 1 us23918k1088_013124.txt us23918k1088_013124.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 8) DAVITA INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 23918K108 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 23918K108 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 4275385 (6) Shared voting power 0 (7) Sole dispositive power 4790419 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 4790419 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 5.2% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- DAVITA INC Item 1(b) Address of issuer's principal executive offices: -------------------------------------------------------------